Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

1.

Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies.

Kalb SR, Santana WI, Geren IN, Garcia-Rodriguez C, Lou J, Smith TJ, Marks JD, Smith LA, Pirkle JL, Barr JR.

BMC Biochem. 2011 Nov 15;12:58. doi: 10.1186/1471-2091-12-58.

PMID:
22085466
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin.

Garcia-Rodriguez C, Geren IN, Lou J, Conrad F, Forsyth C, Wen W, Chakraborti S, Zao H, Manzanarez G, Smith TJ, Brown J, Tepp WH, Liu N, Wijesuriya S, Tomic MT, Johnson EA, Smith LA, Marks JD.

Protein Eng Des Sel. 2011 Mar;24(3):321-31. doi: 10.1093/protein/gzq111. Epub 2010 Dec 13.

PMID:
21149386
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Recombinant anthrax toxin receptor-Fc fusion proteins produced in plants protect rabbits against inhalational anthrax.

Wycoff KL, Belle A, Deppe D, Schaefer L, Maclean JM, Haase S, Trilling AK, Liu S, Leppla SH, Geren IN, Pawlik J, Peterson JW.

Antimicrob Agents Chemother. 2011 Jan;55(1):132-9. doi: 10.1128/AAC.00592-10. Epub 2010 Oct 18.

PMID:
20956592
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies.

Kalb SR, Lou J, Garcia-Rodriguez C, Geren IN, Smith TJ, Moura H, Marks JD, Smith LA, Pirkle JL, Barr JR.

PLoS One. 2009;4(4):e5355. doi: 10.1371/journal.pone.0005355. Epub 2009 Apr 28.

PMID:
19399171
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.

Levy R, Forsyth CM, LaPorte SL, Geren IN, Smith LA, Marks JD.

J Mol Biol. 2007 Jan 5;365(1):196-210. Epub 2006 Oct 3.

PMID:
17059824
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.

Smith TJ, Lou J, Geren IN, Forsyth CM, Tsai R, Laporte SL, Tepp WH, Bradshaw M, Johnson EA, Smith LA, Marks JD.

Infect Immun. 2005 Sep;73(9):5450-7.

PMID:
16113261
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A.

Razai A, Garcia-Rodriguez C, Lou J, Geren IN, Forsyth CM, Robles Y, Tsai R, Smith TJ, Smith LA, Siegel RW, Feldhaus M, Marks JD.

J Mol Biol. 2005 Aug 5;351(1):158-69.

PMID:
16002090
[PubMed - indexed for MEDLINE]
8.

Beta-thalassemia in Iran: a high incidence of the nonsense codon 39 mutation on the island of Queshm.

Noori-Daloii MR, Moazami N, Farhangi S, Atalay A, Geren IN, Akar L, Atalay EO, Cirakoglu B, Bermek E.

Hemoglobin. 1994 Nov;18(6):449-53. No abstract available.

PMID:
7713751
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk